Should triple-positive breast cancer be recognized as a distinct subtype?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)1011-1014
Number of pages4
JournalExpert Review of Anticancer Therapy
Volume20
Issue number12
DOIs
Publication statusPublished - Oct 6 2020

Keywords

  • Breast cancer
  • her2-positive
  • hormone receptor
  • targeted therapy
  • triple positive

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this